This is the authors' abstract. We don't add key points for this paper.
The activation of STAT3 is a crossroads of cellular regulation, induced in its canonical pathway by phosphorylation on a critical tyrosine residue (Y705). The existence of a STAT3 non-canonical signaling mechanisms, induced by phosphorylation at serine 727 (S727), has been recently identified in vitro. After cytoplasmic activation, non-canonical STAT3 could move to the level of mitochondria-endoplasmic reticulum contacts (MERCs). We have previously shown that LPS injections in mouse model induce STAT3 canonical pathway, leading to its nuclear translocation and to neuroinflammation. However, the effects of LPS on activation of the non-canonical pathway and its consequences on protein complexes of MERCs remain to be determined. In an in vivo LPS mouse model, we found that systemic inflammation induces in hippocampus the non-canonical STAT3 pathway. LPS-induced STAT3 affects specifically MERC protein BAP31, and that of a mitochondrial membrane protein known to interact with it, TOM40. These findings shed light on the role of STAT3 on mitochondrial – endoplasmic reticulum interaction under inflammatory conditions, offering new perspectives for targeting mitochondrial function and STAT3 activation in disease contexts. • Systemic inflammation activates in vivo the STAT3 non-canonical pathway via phosphorylation at Serine 727. • Activation of the non-canonical pathway leads to a specific increase in BAP31 protein levels. • Increase in BAP31 protein levels is associated with TOM40 augmentation and may be reversed by a STAT3 inhibitor (Stattic).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Millot et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: